Cannara Biotech Inc. (TSX:LOVE)

Cannara Biotech Income Statement

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Operating Revenue	112.67	106.86	81.65	57.07	35.48	16.29
Other Revenue	0.34	0.34	0.09	0.19	0.36	0.73
Revenue	113.01	107.2	81.75	57.26	35.84	17.02
Revenue Growth (YoY)	20.14%	31.14%	42.77%	59.76%	110.58%	567.25%
Cost of Revenue	65.01	60.1	51.96	30.03	18.51	6.72
Gross Profit	48	47.1	29.79	27.23	17.33	10.3
Selling, General & Admin	24.21	21.98	17.67	11.77	9.68	6.98
Research & Development	1.06	0.71	1.12	1.03	1.26	1.91
Amortization of Goodwill & Intangibles	-	1.56	1.38	0.96	1.23	1.03
Operating Expenses	30.17	25.44	22.14	15.51	12.51	10.24
Operating Income	17.83	21.66	7.64	11.72	4.82	0.05
Interest Expense	-2.82	-3.77	-4.85	-4.74	-2.23	-1.71
Interest & Investment Income	0.32	0.28	0.18	0.24	0.09	0.05
Currency Exchange Gain (Loss)	0.02	-0	-0.12	0.07	0.03	-0.11
Other Non Operating Income (Expenses)	-0.57	-0.59	-0.82	-0.56	-0.53	-0.02
EBT Excluding Unusual Items	14.78	17.59	2.04	6.72	2.18	-1.73
Gain (Loss) on Sale of Assets	0.3	0.42	2.03	-0.13	-0.05	-0.07
Other Unusual Items	0.11	0.09	0.41	0.36	0.17	0.27
Pretax Income	15.19	18.1	4.48	6.95	2.31	-1.53
Income Tax Expense	5.04	5.02	-1.95	-	-	-
Earnings From Continuing Operations	10.16	13.08	6.44	6.95	2.31	-1.53
Net Income	10.16	13.08	6.44	6.95	2.31	-1.53
Net Income to Common	10.16	13.08	6.44	6.95	2.31	-1.53
Net Income Growth	-24.18%	103.09%	-7.30%	201.26%	-	-
Shares Outstanding (Basic)	93	91	90	89	88	77
Shares Outstanding (Diluted)	95	92	91	90	88	77
Shares Change (YoY)	3.00%	1.08%	1.83%	2.16%	14.80%	7.26%
EPS (Basic)	0.11	0.14	0.07	0.08	0.03	-0.02
EPS (Diluted)	0.11	0.14	0.07	0.08	0.03	-0.10
EPS Growth	-21.69%	100.00%	-10.00%	195.77%	-	-
Free Cash Flow	16.11	13.65	3.21	-3.97	-21.55	-33.17
Free Cash Flow Per Share	0.17	0.15	0.04	-0.04	-0.24	-0.43
Gross Margin	42.47%	43.94%	36.44%	47.56%	48.35%	60.49%
Operating Margin	15.78%	20.20%	9.35%	20.46%	13.45%	0.31%
Profit Margin	8.99%	12.20%	7.88%	12.13%	6.43%	-8.98%
Free Cash Flow Margin	14.26%	12.74%	3.93%	-6.93%	-60.11%	-194.86%
EBITDA	23.94	28.06	13.74	16.53	8.62	2.75
EBITDA Margin	21.18%	26.18%	16.81%	28.87%	24.06%	16.18%
D&A For EBITDA	6.11	6.4	6.1	4.82	3.8	2.7
EBIT	17.83	21.66	7.64	11.72	4.82	0.05
EBIT Margin	15.78%	20.20%	9.35%	20.46%	13.45%	0.31%
Effective Tax Rate	33.15%	27.74%	-	-	-	-
Revenue as Reported	112.95	107.32	82.15	57.56	36	17.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.